Literature DB >> 22056390

Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.

Thomas G Magaldi1, Laura L Almstead, Stefania Bellone, Edward G Prevatt, Alessandro D Santin, Daniel DiMaio.   

Abstract

Repression of human papillomavirus (HPV) E6 and E7 oncogenes in established cervical carcinoma cell lines causes senescence due to reactivation of cellular tumor suppressor pathways. Here, we determined whether ongoing expression of HPV16 or HPV18 oncogenes is required for the proliferation of primary human cervical carcinoma cells in serum-free conditions at low passage number after isolation from patients. We used an SV40 viral vector expressing the bovine papillomavirus E2 protein to repress E6 and E7 in these cells. To enable efficient SV40 infection and E2 gene delivery, we first incubated the primary cervical cancer cells with the ganglioside GM1, a cell-surface receptor for SV40 that is limiting in these cells. Repression of HPV in primary cervical carcinoma cells caused them to undergo senescence, but the E2 protein had little effect on HPV-negative primary cells. These data suggest that E6 and E7 dependence is an inherent property of human cervical cancer cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056390      PMCID: PMC3229657          DOI: 10.1016/j.virol.2011.10.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  73 in total

1.  Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.

Authors:  M S Moon; C J Lee; S J Um; J S Park; J M Yang; E S Hwang
Journal:  Gynecol Oncol       Date:  2001-02       Impact factor: 5.482

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 3.  Uptake and metabolism of exogenous glycosphingolipids by cultured cells.

Authors:  G Schwarzmann
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

4.  Rapid induction of senescence in human cervical carcinoma cells.

Authors:  E C Goodwin; E Yang; C J Lee; H W Lee; D DiMaio; E S Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways.

Authors:  S I Wells; D A Francis; A Y Karpova; J J Dowhanick; J D Benson; P M Howley
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

6.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.

Authors:  Ming Jiang; Jo Milner
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

8.  Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.

Authors:  Chan Jae Lee; Eun Jung Suh; Hyun Tae Kang; Jun Sub Im; Soo Jong Um; Jong Sup Park; Eun Seong Hwang
Journal:  Exp Cell Res       Date:  2002-07-15       Impact factor: 3.905

9.  Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.

Authors:  Rosa Anna DeFilippis; Edward C Goodwin; Lingling Wu; Daniel DiMaio
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.

Authors:  Shanaz H Dairkee; Youngran Ji; Yong Ben; Dan H Moore; Zhenhang Meng; Stefanie S Jeffrey
Journal:  BMC Genomics       Date:  2004-07-19       Impact factor: 3.969

View more
  30 in total

1.  Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors.

Authors:  Luqman Jubair; Sora Fallaha; Nigel A J McMillan
Journal:  Mol Ther       Date:  2019-08-29       Impact factor: 11.454

2.  Noninvasive assessment of mitochondrial organization in three-dimensional tissues reveals changes associated with cancer development.

Authors:  Joanna Xylas; Antonio Varone; Kyle P Quinn; Dimitra Pouli; Margaret E McLaughlin-Drubin; Hong-Thao Thieu; Maria L Garcia-Moliner; Michael House; Martin Hunter; Karl Munger; Irene Georgakoudi
Journal:  Int J Cancer       Date:  2014-06-05       Impact factor: 7.396

3.  Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism.

Authors:  Thomas G Magaldi; Michael H C Buch; Haruhiko Murata; Kimberly D Erickson; Ursula Neu; Robert L Garcea; Keith Peden; Thilo Stehle; Daniel DiMaio
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

4.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

5.  High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.

Authors:  Norifumi Iijima; Edward C Goodwin; Daniel Dimaio; Akiko Iwasaki
Journal:  Virology       Date:  2013-07-18       Impact factor: 3.616

6.  Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis.

Authors:  Gordana Halec; Markus Schmitt; Sam Egger; Christian C Abnet; Chantal Babb; Sanford M Dawsey; Christa Flechtenmacher; Tarik Gheit; Martin Hale; Dana Holzinger; Reza Malekzadeh; Philip R Taylor; Massimo Tommasino; Margaret I Urban; Tim Waterboer; Michael Pawlita; Freddy Sitas
Journal:  Int J Cancer       Date:  2016-01-21       Impact factor: 7.396

Review 7.  Human tumour viruses and the deregulation of cell polarity in cancer.

Authors:  Lawrence Banks; David Pim; Miranda Thomas
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

8.  Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.

Authors:  J E Hanning; H K Saini; M J Murray; S van Dongen; M P A Davis; E M Barker; D M Ward; C G Scarpini; A J Enright; M R Pett; N Coleman
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

9.  The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation.

Authors:  Ling-juan Gao; Ping-qing Gu; Wei Zhao; Wen-yan Ding; Xue-qing Zhao; Shu-yu Guo; Tian-ying Zhong
Journal:  J Transl Med       Date:  2013-05-08       Impact factor: 5.531

10.  Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.

Authors:  André Mischo; Oliver Ohlenschläger; Peter Hortschansky; Ramadurai Ramachandran; Matthias Görlach
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.